David O. Watson, General Counsel at Apellis Pharmaceuticals, Inc. (APLS), sold 8,480 shares at $66.81 ($567K) on 2024-01-16, disclosed to the SEC on 2024-01-17.
Seasonal sale ($567k) by General Counsel — this insider has traded APLS in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.81 | 4,240 | $283K | 50.0% |
| 2 | $66.81 | 4,240 | $283K | 50.0% |
| Total | $66.81 avg | 8,480 | $567K | 100% |
| Filing → |
| APLS | SELL | 2026-01-15 | $128K | — | Filing → |
| APLS | SELL | 2025-12-18 | $245K | — | Filing → |
| APLS | SELL | 2025-11-18 | $100K | — | Filing → |